Il Terziario.info

news, commenti e approfondimenti sul terziario italiano

Monday
May 17th
Text size
  • Increase font size
  • Default font size
  • Decrease font size
Home Service Industry news Tertiary news Roivant and Poxel Announce Strategic Agreement for Development and Commercialization of Imeglimin in the U.S., Europe, and Additional Countries Worldwide

Roivant and Poxel Announce Strategic Agreement for Development and Commercialization of Imeglimin in the U.S., Europe, and Additional Countries Worldwide

BASEL, Switzerland & LYON, France--( , a global healthcare company focused on realizing the full value of promising biomedical research, and POXEL SA (Euronext: POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders including....


Posted: 2018-02-12 08:47:00

Leggi tutto